» Articles » PMID: 29515464

Localization and Expression of Nuclear Factor of Activated T-Cells 5 in Myoblasts Exposed to Pro-inflammatory Cytokines or Hyperosmolar Stress and in Biopsies from Myositis Patients

Abstract

Regeneration in skeletal muscle relies on regulated myoblast migration and differentiation, in which the transcription factor nuclear factor of activated T-cells 5 (NFAT5) participates. Impaired muscle regeneration and chronic inflammation are prevalent in myositis. Little is known about the impact of inflammation on NFAT5 localization and expression in this group of diseases. The goal of this study was to investigate NFAT5 physiology in unaffected myoblasts exposed to cytokine or hyperosmolar stress and in myositis. NFAT5 intracellular localization and expression were studied using a cell culture model of myositis. Myoblasts were exposed to DMEM solutions enriched with pro-inflammatory cytokines IFN-γ with IL-1β or hyperosmolar DMEM obtained by NaCl supplementation. NFAT5 localization was visualized using immunohistochemistry (IHC) and Western blotting (WB) in fractionated cell lysates. NFAT5 expression was assessed by WB and RT-qPCR. localization and expression of NFAT5 were studied in muscle biopsies of patients diagnosed with polymyositis ( = 6), dermatomyositis ( = 10), inclusion body myositis ( = 11) and were compared to NFAT5 localization and expression in non-myopathic controls ( = 13). Muscle biopsies were studied by means of quantitative IHC and WB of total protein extracts. In unaffected myoblasts, hyperosmolar stress ensues in NFAT5 nuclear translocation and increased NFAT5 mRNA and protein expression. In contrast, pro-inflammatory cytokines did not lead to NFAT5 nuclear translocation nor increased expression. Cytokines IL-1β with IFN-γ induced colocalization of NFAT5 with histone deacetylase 6 (HDAC6), involved in cell motility. In muscle biopsies from dermatomyositis and polymyositis patients, NFAT5 colocalized with HDAC6, while in IBM, this was often absent. Our data suggest impaired NFAT5 localization and expression in unaffected myoblasts in response to inflammation. This disturbed myogenic NFAT5 physiology could possibly explain deleterious effects on muscle regeneration in myositis.

Citing Articles

TonEBP inhibits ciliogenesis by controlling aurora kinase A and regulating centriolar satellite integrity.

Chinbold B, Kwon H, Park R Cell Commun Signal. 2024; 22(1):348.

PMID: 38961488 PMC: 11221002. DOI: 10.1186/s12964-024-01721-8.


NFAT5 Restricts Bovine Herpesvirus 1 Productive Infection in MDBK Cell Cultures.

Liu C, Lin J, Yang H, Li N, Tang L, Neumann D Microbiol Spectr. 2023; 11(4):e0011723.

PMID: 37227295 PMC: 10434061. DOI: 10.1128/spectrum.00117-23.


The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target.

Herbelet S, Merckx C, De Paepe B Biomedicines. 2021; 9(4).

PMID: 33808305 PMC: 8066813. DOI: 10.3390/biomedicines9040350.


Description of a Novel Mechanism Possibly Explaining the Antiproliferative Properties of Glucocorticoids in Duchenne Muscular Dystrophy Fibroblasts Based on Glucocorticoid Receptor GR and NFAT5.

Herbelet S, De Paepe B, De Bleecker J Int J Mol Sci. 2020; 21(23).

PMID: 33287327 PMC: 7731298. DOI: 10.3390/ijms21239225.


Abnormal NFAT5 Physiology in Duchenne Muscular Dystrophy Fibroblasts as a Putative Explanation for the Permanent Fibrosis Formation in Duchenne Muscular Dystrophy.

Herbelet S, De Paepe B, De Bleecker J Int J Mol Sci. 2020; 21(21).

PMID: 33114289 PMC: 7660673. DOI: 10.3390/ijms21217888.


References
1.
Morosetti R, Mirabella M, Gliubizzi C, Broccolini A, De Angelis L, Tagliafico E . MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A. 2006; 103(45):16995-7000. PMC: 1636567. DOI: 10.1073/pnas.0603386103. View

2.
Dalakas M . Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991; 325(21):1487-98. DOI: 10.1056/NEJM199111213252107. View

3.
De Paepe B, Martin J, Herbelet S, Jimenez-Mallebrera C, Iglesias E, Jou C . Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism. Lab Invest. 2016; 96(8):872-84. DOI: 10.1038/labinvest.2016.68. View

4.
Kim J, Kwon M, Lee-Kwon W, Choi S, Sanada S, Kwon H . Modulation of TonEBP activity by SUMO modification in response to hypertonicity. Front Physiol. 2014; 5:200. PMC: 4063170. DOI: 10.3389/fphys.2014.00200. View

5.
Benveniste O, Stenzel W, Hilton-Jones D, Sandri M, Boyer O, van Engelen B . Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol. 2015; 129(5):611-24. PMC: 4405277. DOI: 10.1007/s00401-015-1384-5. View